The bill, introduced by Bowers as H.B. No. 1987, aims to regulate abortion practices in Texas, specifically focusing on abortion complication reporting and repealing certain existing laws that prohibit abortion. Key amendments include the definition of "abortion complication," which now encompasses a broader range of adverse outcomes, including the birth of an infant alive after an abortion. The bill also specifies that reporting requirements apply to physicians and health care facilities involved in diagnosing or treating abortion complications. Additionally, it introduces new definitions related to abortion-inducing drugs, emphasizing compliance with protocols established by the United States Food and Drug Administration (FDA).

Furthermore, the bill outlines the conditions under which abortion-inducing drugs may be provided, mandating that they adhere to FDA-approved protocols and allowing for dosage amounts based on clinical management guidelines from the American College of Obstetricians and Gynecologists. It also requires physicians to document the gestational age and location of the pregnancy before administering the drug and mandates a follow-up visit to confirm the termination of the pregnancy. The legislation repeals several existing provisions related to abortion, signaling a significant shift in the regulatory landscape surrounding abortion practices in Texas. The bill is set to take effect on September 1, 2025.

Statutes affected:
Introduced: Health and Safety Code 171.061, Health and Safety Code 171.063, Health and Safety Code 171.206, Health and Safety Code 171.207 (Health and Safety Code 171)